Merck Serono S. A.

Zymogenetics, Inc.

Ares Trading S.a.

Alain Munafo

Jane A Gross

Sharon J Busby

Maria Lopez-Bresnahan

Arnaud Ythier

Giampiero De Luca

Orestis Papasouliotis

Claudia Pena Rossi

Amaud Ythier

Arnoud Ythier

The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.

Cladribine regimen for treating multiple sclerosis

The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be orally administered and wherein re-treatments are possible.

Growing community of inventors

Tartegnin, Switzerland

Alain Munafo